Theranostics: building the bridge between nuclear medicine and radiation oncology
Source ↗
👁 1
💬 0
In the ongoing quest to improve cancer treatments, the radiation oncology community is looking to add to its armoury of radiation-based treatments. In particular, radiopharmaceutical therapy (RPT) – also known as molecular radiotherapy (MRT) – and the emerging sub-field of theranostics are set to play an expanded role as radiation medicine shifts towards a more integrated, multidisciplinary approach.
RPT is an evolving modality that uses a tumour-targeting molecule attached to a therapeutic radi
RPT is an evolving modality that uses a tumour-targeting molecule attached to a therapeutic radi
Comments (0)